top of page
Home
About Us
Publications
Voice of Customer
Investors
News
Data Room
More
Use tab to navigate through the menu items.
Newsroom
All Posts
Science & Research
Women’s Health
Endometriosis
Investment & Market
Company News
Clinical Development
Patient Advocacy
Company News
Publications
Sur180 Therapeutics Featured on Notiséis WIPR
Sur180 Therapeutics CEO Dr. Annelyn Torres-Reverón was featured on Notiséis WIPR, discussing the company’s mission and its novel non-hormonal approach to treating endometriosis.
Mar 26
1 min read
Our Novel Treatment Recognized by Leading Media
bottom of page
